Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 1–15 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-6038 6q24‑Related Transient Neonatal Diabetes Mellitus Type 1 (TNDM) Genetic Test This genetic test detects paternal uniparental disomy of chromosome 6 (UPD(6)pat), the hallmark of 6q24-related Transient Neonatal Diabetes Mellitus Type 1.	Whole blood, extracted DNA, or dried blood spot (FTA card)	21–28 working days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Paternal uniparental disomy of chromosome 6 (UPD(6)pat)", "Chromosome 6 copy number variation"] Parameters [] Preparation ["No fasting required for the neonate", "Mandatory genetic counselling session and signed informed consent prior to sample collection"] Indications ["Diagnosis of 6q24-related Transient Neonatal Diabetes Mellitus Type 1 (TNDM1)", "Differentiation from permanent neonatal diabetes", "Genetic counselling for families with affected neonates"] Measurement technique Confirm with laboratory Codes LOINC: 81226-5 ICD-10: P70.2 Clinical summary This genetic test detects paternal uniparental disomy of chromosome 6 (UPD(6)pat), the hallmark of 6q24-related Transient Neonatal Diabetes Mellitus Type 1.
TEST-3705 AAAS Gene (Achalasia-Addisonianism-Alacrimia Syndrome) Next-Generation Sequencing (NGS) Genetic Test This test evaluates the AAAS gene for mutations associated with Triple A (Allgrove) syndrome, a rare disorder affecting the esophagus, adrenal glands, and tear ducts.	Peripheral Whole Blood	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AAAS gene variants", "Single nucleotide variants", "Insertions/deletions", "Splice-site mutations"] Parameters [] Preparation ["No special preparation required", "Inform phlebotomist of bleeding disorders or anticoagulant use", "Consult endocrinologist regarding stress-dose steroids if adrenal insufficiency is suspected"] Indications ["Clinical suspicion of Triple A syndrome", "Confirmation of diagnosis", "Genetic counseling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 81261-3 ICD-10: E27.4, K22.0, H04.2 Clinical summary This test evaluates the AAAS gene for mutations associated with Triple A (Allgrove) syndrome, a rare disorder affecting the esophagus, adrenal glands, and tear ducts.
TEST-4848 AAGAB Gene Keratoderma, Palmoplantar, Punctate Type 1A Genetic Test This genetic test evaluates the AAGAB gene for pathogenic variants associated with palmoplantar punctate keratoderma type 1A.	Whole blood (EDTA), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AAGAB gene", "Coverage of coding regions"] Parameters [] Preparation ["Informed consent required", "Genetic counselling recommended"] Indications ["Diagnosis of palmoplantar punctate keratoderma type 1A", "Differential diagnosis of skin disorders", "Pre-symptomatic screening", "Family carrier detection"] Measurement technique Confirm with laboratory Codes LOINC: 81247-7 ICD-10: Q82.8, Z15.09, L98.8 Clinical summary This genetic test evaluates the AAGAB gene for pathogenic variants associated with palmoplantar punctate keratoderma type 1A.
TEST-4263 AARS1 Gene Early Infantile Epileptic Encephalopathy Type 29 Genetic Test This genetic test identifies pathogenic variants in the AARS1 gene associated with early infantile epileptic encephalopathy type 29.	Peripheral Whole Blood (EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AARS1 gene"] Parameters [] Preparation ["Pre-genetic counselling session required", "Provide completed clinical history questionnaire", "List all medications"] Indications ["Suspected AARS1-related early infantile epileptic encephalopathy (EIEE29)", "Family history of AARS1-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 82930-0 ICD-10: G40.4 Clinical summary This genetic test identifies pathogenic variants in the AARS1 gene associated with early infantile epileptic encephalopathy type 29.
TEST-6270 AARS2 Gene (Combined Oxidative Phosphorylation Deficiency Type 8) DNA Test This test identifies pathogenic variants in the AARS2 gene associated with Combined Oxidative Phosphorylation Deficiency Type 8.	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AARS2 gene", "Coding exons and exon-intron boundaries"] Parameters [] Preparation ["Do not discontinue any prescribed medication without consulting your doctor."] Indications ["Clinical suspicion of mitochondrial disease", "Evaluation for Combined Oxidative Phosphorylation Deficiency Type 8"] Measurement technique Confirm with laboratory Codes LOINC: 101638-4 ICD-10: E74.81 Clinical summary This test identifies pathogenic variants in the AARS2 gene associated with Combined Oxidative Phosphorylation Deficiency Type 8.
TEST-4054 ABCA1 Gene Genetic Test for Coronary Artery Disease & Familial Hypercholesterolemia Susceptibility This test evaluates the ABCA1 gene for pathogenic variants linked to premature coronary artery disease and familial hypercholesterolemia.	Whole Blood / Peripheral Blood	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ABCA1 gene pathogenic variants", "Cholesterol efflux regulation", "HDL metabolism"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant family history"] Indications ["Assessment of hereditary risk for CAD", "Evaluation for familial hypercholesterolemia", "Risk stratification in individuals with dyslipidemia"] Measurement technique Confirm with laboratory Codes LOINC: 92031-4 ICD-10: E78.0, I25.1 Clinical summary This test evaluates the ABCA1 gene for pathogenic variants linked to premature coronary artery disease and familial hypercholesterolemia.
TEST-3356 ABCB7 Gene Sideroblastic Anemia with Ataxia Genetic Test This test sequences the ABCB7 gene to detect pathogenic variants associated with X-linked sideroblastic anemia with ataxia.	Whole Blood (peripheral venous)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ABCB7 gene sequence", "Pathogenic variants in ABCB7"] Parameters [] Preparation ["No specific fasting required", "Avoid recent blood transfusion (within 2 weeks)"] Indications ["Suspected X-linked sideroblastic anemia with ataxia", "Family history of the condition", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 87039-8 ICD-10: D64.0 Clinical summary This test sequences the ABCB7 gene to detect pathogenic variants associated with X-linked sideroblastic anemia with ataxia.
TEST-3887 ABCC2 Gene Dubin-Johnson Syndrome Genetic Test This genetic test evaluates the ABCC2 gene for mutations associated with Dubin-Johnson syndrome.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mutations in the ABCC2 gene", "Exons and flanking regions of the ABCC2 gene"] Parameters [{"name": "Method", "reference_range": "Next-Generation Sequencing (NGS)"}, {"name": "Detection Sensitivity", "reference_range": "99.9%"}, {"name": "Turnaround Time", "reference_range": "3–4 Weeks"}] Preparation ["No fasting required", "Continue prescribed medications"] Indications ["Diagnosis of Dubin-Johnson syndrome", "Family risk assessment", "Differentiation from other causes of hyperbilirubinemia"] Measurement technique Confirm with laboratory Codes LOINC: 69047-9 ICD-10: E80.6 Clinical summary This genetic test evaluates the ABCC2 gene for mutations associated with Dubin-Johnson syndrome.
TEST-4637 ABCC6 Gene Pseudoxanthoma Elasticum (Forme Fruste) Genetic Test This genetic test evaluates the ABCC6 gene for pathogenic variants associated with pseudoxanthoma elasticum (PXE) and its forme fruste presentation.	Peripheral Whole Blood	3–4 Weeks (Express: 14 Business Days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ABCC6 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variants (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of recent blood transfusions (wait 4 weeks)", "Inform lab of bleeding disorders"] Indications ["Suspicion of Pseudoxanthoma Elasticum (PXE)", "Family history of PXE", "Carrier screening", "Differential diagnosis of skin or vascular conditions"] Measurement technique Confirm with laboratory Codes LOINC: 99157-1 ICD-10: Q82.8 Clinical summary This genetic test evaluates the ABCC6 gene for pathogenic variants associated with pseudoxanthoma elasticum (PXE) and its forme fruste presentation.
TEST-4617 ABCC6 Gene Pseudoxanthoma Elasticum Genetic Test This genetic test analyzes the ABCC6 gene to detect pathogenic variants associated with pseudoxanthoma elasticum (PXE).	Whole Blood or DNA FTA Card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ABCC6 gene", "Genetic predisposition to Pseudoxanthoma Elasticum"] Parameters [] Preparation ["No fasting required", "Inform phlebotomist of anticoagulant medications"] Indications ["Diagnosis of suspected Pseudoxanthoma Elasticum (PXE)", "Genetic counseling for families with PXE", "Clinical management of PXE patients"] Measurement technique Confirm with laboratory Codes LOINC: 20316-4 ICD-10: Q82.8 Clinical summary This genetic test analyzes the ABCC6 gene to detect pathogenic variants associated with pseudoxanthoma elasticum (PXE).
TEST-4041 ABCC6 Gene Sequencing for Generalized Arterial Calcification Type 2 (Infantile) Test This test identifies pathogenic variants within the ABCC6 gene, the primary cause of Generalized Arterial Calcification of Infancy (GACI) type 2.	Peripheral whole blood (EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ABCC6 gene", "Copy number variants in the ABCC6 gene"] Parameters [] Preparation [] Indications ["Diagnosis of GACI type 2", "Family planning for GACI type 2"] Measurement technique Confirm with laboratory Codes LOINC: 21615-9 ICD-10: E83.59 Clinical summary This test identifies pathogenic variants within the ABCC6 gene, the primary cause of Generalized Arterial Calcification of Infancy (GACI) type 2.
TEST-6126 ABCC8 Gene (Hypoglycemia of Infancy, Leucine-Sensitive) Next‑Generation Sequencing Genetic Test This test identifies pathogenic variants in the ABCC8 gene associated with congenital hyperinsulinism and leucine-sensitive hypoglycemia.	Peripheral Whole Blood (3–5 mL in EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ABCC8 gene sequence", "Pathogenic variants in coding exons and splice sites"] Parameters [] Preparation ["Genetic counselling session required prior to sample collection", "Detailed family pedigree required prior to sample collection"] Indications ["Diagnosis of congenital hyperinsulinism", "Identification of leucine-sensitive hypoglycemia", "Genetic counselling for families with affected individuals"] Measurement technique Confirm with laboratory Codes LOINC: 81198-4 ICD-10: E16.1 Clinical summary This test identifies pathogenic variants in the ABCC8 gene associated with congenital hyperinsulinism and leucine-sensitive hypoglycemia.
TEST-6241 ABCC8 Gene Hyperinsulinemic Hypoglycemia Type 1 Genetic Test This genetic test detects pathogenic variants in the ABCC8 gene associated with congenital hyperinsulinemic hypoglycemia type 1.	Whole Blood (1 mL) or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ABCC8 gene", "Coding region analysis"] Parameters [] Preparation ["No fasting required", "No medication adjustment needed unless directed by doctor"] Indications ["Suspected congenital hyperinsulinemic hypoglycemia", "Need to differentiate diffuse from focal disease", "Guiding treatment planning for hyperinsulinism"] Measurement technique Confirm with laboratory Codes LOINC: 97920-5 ICD-10: E16.1, Z13.79, Z84.89 Clinical summary This genetic test detects pathogenic variants in the ABCC8 gene associated with congenital hyperinsulinemic hypoglycemia type 1.
TEST-4423 ABCC9 Gene Atrial Fibrillation Type 12 Genetic Test This test evaluates the ABCC9 gene for pathogenic variants associated with familial atrial fibrillation type 12.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ABCC9 gene", "Single nucleotide variants", "Small insertions or deletions"] Parameters [] Preparation ["Mandatory pre-test genetic counseling teleconsultation"] Indications ["Individuals with a strong family history of early-onset atrial fibrillation", "Patients with unexplained atrial fibrillation and a suggestive pedigree", "Individuals with atrial fibrillation and cardiomyopathy"] Measurement technique Confirm with laboratory Codes LOINC: 81269-7 ICD-10: I48.0, I48.1, I48.2, I48.3, I48.4, I48.91 Clinical summary This test evaluates the ABCC9 gene for pathogenic variants associated with familial atrial fibrillation type 12.
TEST-6036 ABCD4 Gene Methylmalonic Aciduria CblJ Type Genetic Test This test identifies pathogenic variants in the ABCD4 gene, confirming a diagnosis of methylmalonic aciduria, CblJ type.	5 mL EDTA Whole Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ABCD4 gene sequence", "Pathogenic variants"] Parameters [] Preparation ["Complete pre-test genetic counselling session", "Avoid blood transfusion within 14 days prior to collection"] Indications ["Suspected methylmalonic aciduria, CblJ type", "Family cascade screening"] Measurement technique Confirm with laboratory Codes LOINC: 21656-9 ICD-10: E71.120 Clinical summary This test identifies pathogenic variants in the ABCD4 gene, confirming a diagnosis of methylmalonic aciduria, CblJ type.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.